fosphenytoin has been researched along with celecoxib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nightingale, SL | 1 |
1 review(s) available for fosphenytoin and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for fosphenytoin and celecoxib
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Arthritis; Celecoxib; Communicable Diseases; Cyclooxygenase Inhibitors; Drug Contamination; Drug Labeling; Humans; Phenytoin; Plasminogen Activators; Prodrugs; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Urokinase-Type Plasminogen Activator | 1999 |
Celebrex mix-up.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Carrier Proteins; Celecoxib; Humans; Medication Errors; Names; Phenytoin; Pyrazoles; Receptors, Drug; Sulfonamides | 1999 |